Follow
Alex C.H. Liu 劉承寰
Alex C.H. Liu 劉承寰
Graduate student, University of Toronto
Verified email at mail.utoronto.ca
Title
Cited by
Cited by
Year
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation
Z Xu, JH Choi, DL Dai, J Luo, RJ Ladak, Q Li, Y Wang, C Zhang, S Wiebe, ...
Proceedings of the National Academy of Sciences 119 (32), e2204539119, 2022
602022
Plasmon-activated water reduces amyloid burden and improves memory in animals with alzheimer’s disease
CH Cheng, KJ Lin, CT Hong, D Wu, HM Chang, CH Liu, IT Hsiao, ...
Scientific Reports 9 (1), 13252, 2019
192019
Targeting STAT5 signaling overcomes resistance to IDH inhibitors in acute myeloid leukemia through suppression of stemness
ACH Liu, S Cathelin, Y Yang, DL Dai, DM Ayyathan, M Hosseini, ...
Cancer Research 82 (23), 4325-4339, 2022
82022
STAT5 Signaling Promotes Resistance to Ivosidenib in IDH1-Mutated AML
A Liu, S Cathelin, SM Chan
Blood 138, 210, 2021
22021
Metformin reduces the clonal fitness of Dnmt3aR878H hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic state
M Hosseini, V Voisin, A Chegini, A Varesi, S Cathelin, DM Ayyathan, ...
Research Square, 2024
12024
TET2 Deficiency Increases the Competitive Advantage of Hematopoietic Stem Cells through Upregulation of Thrombopoietin Receptor Signaling
S Chan, Y Yang, S Cathelin, A Liu, A Subedi, A Maher, M Hosseini, ...
2024
Metformin Treatment Abrogates the Competitive Advantage of Dnmt3a R878H HSPCs By Enhancing DNA Methylation Activity
M Hosseini, S Cathelin, A Liu, Y Yang, A Subedi, D Manikoth Ayyathan, ...
Blood 140 (Supplement 1), 977-978, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7